The Clinical Sciences Core will be led by Dr. Margaret FischI as Director, Dr. Charles Mitchell as Co- Director, and Dr. Kristopher Arheart as Biostatistical Subcore leader. The Clinical Sciences Core (CSC) during the past four years provided essential services that both enhanced the productivity and capacity of Miami CFAR investigators and new/young investigators and fostered collaborative research among clinical, behavioral/social, and basic scientists that involved human subjects, human data, and biological specimen collection and distribution. The CSC provided support and services to over 80 investigators for over 120 projects support by 7 NIH institutes, 6 NIH funded networks, the CDC, the HRSA, and the pharmaceutical industry and to over 100 CFAR members including young/new investigators. The mission of the CSC is to provide scientific leadership and infrastructure support that advances multidisciplinary collaborative research in basic, clinical, epidemiologic, behavioral/social, and translational sciences in the prevention, detection, treatment, and cure of HIV/AIDS. The mission and goals of the CSC are needs base driven by the research priorities of the UM CFAR investigators and their projects and by the CSC priority to foster synergy and produce an economy of scale. The CSC will focus on enhancing the capacity for HIV/AIDS research in NIH Networks, promoting and supporting innovative NIH HIV/AIDS research initiatives, and facilitating and promoting scientific interactions between CFAR investigators and industry. The CSC will accomplish this through the provision of Biostatistical study design expertise and biostatical services, provision of clinical data and biological specimen repository to foster collaborative immunopathogenesis research, assistance with IRB and regulatory agency submissions, and provision of state-of-the-art clinical research facilities with clinical services. The CSC is essential to the continued growth and success of the Miami CFAR, as it has provided critical expertise and services for advancing multidisciplinary clinical translation research in therapeutic, vaccine and prevention research that is not duplicated by other Cores or facilities at the University of Miami.

Public Health Relevance

The CSC will support and stimulate scientific interdisciplinary translational research through the provision of scientific expertise and services with the goal to ehance and advance translational sciences in the prevention, detection, treatment, and cure of HIV/AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI073961-06
Application #
8294235
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$297,067
Indirect Cost
$69,281
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Cohen, Stephanie E; Vittinghoff, Eric; Bacon, Oliver et al. (2015) High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr 68:439-48
Liu, Sicen; Dominska-Ngowe, Monika; Dykxhoorn, Derek Michael (2014) Target silencing of components of the conserved oligomeric Golgi complex impairs HIV-1 replication. Virus Res 192:92-102
András, Ibolya E; Toborek, Michal (2014) HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-?/Smad signaling. Exp Cell Res 323:66-76
Fekete, Erin M; Seay, Julia; Antoni, Michael H et al. (2014) Oxytocin, social support, and sleep quality in low-income minority women living with HIV. Behav Sleep Med 12:207-21
Thomas, Jaime M; Pos, Zoltan; Reinboth, Jennifer et al. (2014) Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens. J Virol 88:10758-66
Ashlock, Brittany M; Ma, Qi; Issac, Biju et al. (2014) Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. PLoS One 9:e87324
Weiss, Stephen M; Peltzer, Karl; Villar-Loubet, Olga et al. (2014) Improving PMTCT uptake in rural South Africa. J Int Assoc Provid AIDS Care 13:269-76
András, Ibolya E; Rampersaud, Evadnie; Eum, Sung Yong et al. (2014) Transcriptional profile of HIV-induced nuclear translocation of amyloid ? in brain endothelial cells. Arch Med Res 45:744-52
Mesri, Enrique A; Feitelson, Mark A; Munger, Karl (2014) Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe 15:266-82
Johnson, Daniel H; Venuto, Charles; Ritchie, Marylyn D et al. (2014) Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics 24:195-203

Showing the most recent 10 out of 59 publications